ResearchEfficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial
ResearchFostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development
ResearchIncreasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023
ResearchDefining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets
ResearchPatient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations
ResearchExploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop
ResearchInterleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
ResearchUpdating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group
ResearchPhysicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies
ResearchWhat are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?
ResearchImproving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set
ResearchMeasurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review
ResearchPain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018